Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), H2 receptor antagonists(Histamine H2 receptor antagonists), DNA alkylating agents + [1] |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC10H16N6S |
InChIKeyAQIXAKUUQRKLND-UHFFFAOYSA-N |
CAS Registry51481-61-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Phase 2 | IL | 01 Jan 2012 | |
Pancreatic Cancer | Phase 2 | US | 01 Jan 2012 | |
Prostatic Cancer | Phase 2 | IL | 01 Mar 2009 |